Zobrazeno 1 - 10
of 28
pro vyhledávání: '"L. V. Wood"'
Autor:
Zhi-Dong Jiang, Herbert L. DuPont, L. V. Wood, Melinda Cox, Javier A. Adachi, John J. Mathewson
Publikováno v:
Journal of Travel Medicine. 7:304-308
Background: Gastric digestion of these antigens plays an important role, decreasing the ability to deliver antigens to the gut-associated lymphoid tissue. To overcome this obstacle, microencapsulated antigens from enterotoxigenic Escherichia coli (ET
Autor:
S Koenig, T R Fuerst, L V Wood, R M Woods, J A Suzich, G M Jones, V F de la Cruz, R T Davey, S Venkatesan, B Moss
Publikováno v:
The Journal of Immunology. 145:127-135
Epitope mapping of a MHC class I-restricted cytotoxic T cell response to nef, a regulatory protein of HIV, was performed with fresh PBMC from HIV-seropositive donors and target cells pulsed with a panel of overlapping peptides of the nef protein. The
Autor:
E. Harrison, M. Nizamuddin, L. V. Wood, S Ishaq, S De Silva, Sheldon C. Cooper, D. Cheema, J Slater
Publikováno v:
Journal of Crohn's and Colitis. 8:S274
Autor:
S, Sei, D P, O'Neill, S K, Stewart, Q, Yang, M, Kumagai, A M, Boler, M A, Adde, S L, Zwerski, L V, Wood, D J, Venzon, I T, Magrath
Publikováno v:
Cancer research. 61(13)
A common polymorphism in the 3' untranslated region of the stromal cell-derived factor 1 (also called pre-B-cell-stimulating factor) beta gene transcript, termed SDF1-3'A, has been associated with an increased risk of non-Hodgkin's lymphoma (NHL) in
Autor:
Shanika de Silva, L. V. Wood, Rupinder Matharu, Monika M. Widlak, Jayne Slater, Amera Elzubeir
Publikováno v:
Gastroenterology. 144:S-411
BackgroundWith the ever increasing use of immunosuppressive therapy for the management of inflammatory bowel disease (IBD), patients are being exposed to infections which can be prevented by vaccinations administered prior to or during therapy. The E
Publikováno v:
Journal of Crohn's and Colitis. 7:S144
Publikováno v:
Journal of Crohn's and Colitis. 7:S178
Publikováno v:
Gut. 61:A232.2-A232
Introduction The role of Mycophenolate mofetil (MMF) as an immunomodulatory drug in managing inflammatory bowel disease is yet to be fully defined. We reviewed our experience of the efficacy, safety and tolerability of MMF in treating patients with r
Publikováno v:
Gut. 61:A177.2-A178
Introduction Ulcerative colitis (UC) has a chronic relapsing course. Infliximab is beneficial in severe disease, but conflicting data exists regarding the subsequent colectomy rates. We aimed to review outcomes post-infliximab usage in acute and sub-
Publikováno v:
Journal of the National Medical Association. 86(10)
This two-part article, the last in a series of articles on cancer emergencies, summarizes the common medical emergencies that can occur as a result of infectious processes (Part I) and antitumor treatment secondary to chemotherapy, biological respons